Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Molecular Mechanisms to Treatment Advancements in Neurodegenerative Disease Research

Tumby Barer*
Institute of System Motor Science, Center of Brain, Behavior and Metabolism, University of Lübeck, Germany
*Corresponding Author: Tumby Barer, Institute of System Motor Science, Center of Brain, Behavior and Metabolism, University of Lübeck, Germany, Email: tumbybarer@gmail.com

Received Date: Sep 03, 2024 / Published Date: Sep 30, 2024

Citation: Tumby B (2024) Molecular Mechanisms to Treatment Advancements inNeurodegenerative Disease Research. Neurol Clin Therapeut J 8: 223.

Copyright: © 2024 Tumby B. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s disease, are characterized by the progressive loss of neuronal function and structure. This review focuses on recent advancements in understanding the molecular mechanisms underlying these diseases and explores emerging therapeutic strategies. We discuss the roles of protein misfiling, mitochondrial dysfunction, oxidative stress, and neuroinflammation in disease progression. Furthermore, we highlight novel treatment approaches, including gene therapy, small molecule inhibitors, and immunotherapy, that aim to target these molecular pathways. By integrating the latest research findings, this review provides a comprehensive overview of the current landscape in neurodegenerative disease research, emphasizing the transition from molecular insights to potential therapeutic applications.

Top